CIM-MEDICA
0550.400.071 · rovalta.com · 26/09/2026
NORMAL SITUATION
CIM-MEDICA
Company — Normal situation.
Financial year 2025 · Closed on 07/03/2025
Net result1,8 k €+118,0 %over 1 year
Gross margin42,5 k €-57,0 %over 1 year
Equity128,7 k €+1,4 %over 1 year
Overview
Identity
Source · BCE/KBOCIM-MEDICA is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0550.400.071
- Legal form
- Private company with limited liability
- Contributed capital
- 36 704,00 €
- Latest accounts
- 07/03/2025
Joint committees (1)
- 218
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 42,5 k € | -57.0% | 98,9 k € | +396% | -33,4 k € | -133% | 102,1 k € | -28.2% | 142,2 k € |
| EBITDA | 11 k € | -85.7% | 76,7 k € | +321% | -34,7 k € | -214% | 30,4 k € | -28.8% | 42,8 k € |
| Operating result | 3,4 k € | -92.2% | 43,1 k € | +181% | -53,3 k € | -511% | 13 k € | +429% | 2,5 k € |
| Net result | 1,8 k € | +118% | -10 k € | +83.9% | -62,1 k € | -1842% | 3,6 k € | +56.4% | 2,3 k € |
| Balance sheet | |||||||||
| Equity | 128,7 k € | +1.4% | 126,9 k € | -7.3% | 136,9 k € | -31.2% | 199 k € | +1.8% | 195,5 k € |
| Total assets | 240,3 k € | +4.8% | 229,3 k € | +57.9% | 145,2 k € | -32.2% | 214,3 k € | +4.9% | 204,2 k € |
| Cash | 20,5 k € | +26.8% | 16,2 k € | – | 11,9 k € | +86.4% | 6,4 k € | ||
| Debts | 111,6 k € | +9.0% | 102,3 k € | +1137% | 8,3 k € | -45.7% | 15,3 k € | +75.1% | 8,7 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 07/03/20251 active · 2 ended
Active mandates
Farid ALSAID
ActiveEnded mandates
Ghinwar ANTAR
EndedGHINWAR ANTAR
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 07/03/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 3 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/12/2025 | 23/09/2025 | 31/08/2024 | 31/08/2023 | 18/11/2022 | 22/10/2021 |
| General meeting | 26/05/2025 | 26/05/2025 | 31/05/2024 | 26/05/2023 | 27/05/2022 | 31/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 07/03/2025 | 26/05/2025 | 03/12/2025 | French | |
| Micro model | 31/12/2024 | 26/05/2025 | 23/09/2025 | French | |
| Micro model | 31/12/2023 | 31/05/2024 | 31/08/2024 | French | |
| Micro model | 31/12/2022 | 26/05/2023 | 31/08/2023 | French | |
| Micro model | 31/12/2021 | 27/05/2022 | 18/11/2022 | French | |
| Micro model | 31/12/2020 | 31/05/2021 | 22/10/2021 | French | |
| Micro model | 31/12/2019 | 25/05/2020 | 11/02/2021 | French | |
| Micro model | 31/12/2018 | 27/05/2019 | 31/10/2019 | French | |
| Micro model | 31/12/2017 | 28/05/2018 | 13/11/2018 | French | |
| Abridged model | 31/12/2016 | 22/05/2017 | 05/12/2017 | French | |
| Abridged model | 31/12/2015 | 30/05/2016 | 04/10/2016 | French | |
| Abridged model | 31/12/2014 | 26/05/2015 | 30/09/2015 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 07/03/20251 active · 2 ended
Active mandates
Farid ALSAID
ActiveEnded mandates
Ghinwar ANTAR
EndedGHINWAR ANTAR
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution25/09/2025RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Registered office30/04/2024SIEGE SOCIAL
- Restructuring29/01/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates03/01/2023DEMISSIONS, NOMINATIONS - SIEGE SOCIAL - MODIFICATION FORME JURIDIQUE
- Mandates05/02/2015DEMISSIONS, NOMINATIONS
- Mandates26/09/2014DEMISSIONS, NOMINATIONS
- Other24/04/2014RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,8 k €↑
- 2024Annual accounts 2024-10 k €↑
- 2023Annual accounts 2023-62,1 k €↓
- 2022Annual accounts 20223,6 k €↑
- 2021Annual accounts 20212,3 k €↑
- 2020Annual accounts 2020-14,2 k €↓
- 2019Annual accounts 201939,9 k €↑
- 2018Annual accounts 201811,9 k €↓
- 2017Annual accounts 201777,4 k €↑
- 2016Annual accounts 20167 k €↓
- 2015Annual accounts 201525,6 k €↓
- 2014Annual accounts 201440,6 k €